On Monday, April 16th, 2012 Foley participated in the BIO IP Counsels Committee Conference, April 16th-18th, at the The Driskill Hotel in Austin, Texas.
The program focused on various changes to U.S. patent law provided by the provisions of the America Invents Act (the “AIA”). Foley Attorneys Lauren Stevens and Debra Nye along with Dan Sharp, The University of Austin Texas and Thomas Kelley, Monsanto Company presented a workshop entitled, “Putting The Pieces Together” discussing the expanded prior commercial use defense (“PCU defense”) of the AIA.
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…